ConductScience.org, home

Paper25201728

Substantial non-electrostatic forces are needed to induce allosteric disruption of thrombin's active site through exosite 2.

Mehta AY and 1 other. Biochem Biophys Res Commun, 2014. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Substantial non-electrostatic forces are needed to induce allosteric disruption of thrombin's active site through exosite 2. Papers, record 25201728. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25201728

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Substantial non-electrostatic forces are needed to induce allosteric disruption of thrombin's active site through exosite 2.
PubMed
Journal
Biochem Biophys Res Commun
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.29
iCite
Revised in PubMed
2021-10-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mehta AYAkul Y
2Desai URUmesh R

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AnticoagulantsMajor topic
LigninMajor topic
ThrombinMajor topic
Allosteric Regulation
Catalytic Domain
Heparin
Kinetics
Molecular Mimicry
Platelet Glycoprotein GPIb-IX Complex
Protein Binding
Sodium Chloride
Static Electricity
Sulfates
Thermodynamics

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 HL107152NHLBI NIH HHSUnited StatesP01HL107152PubMed and NIHNIH RePORTER
R01 HL090586NHLBI NIH HHSUnited StatesR01HL090586PubMed and NIHNIH RePORTER
P01HL107152NHLBI NIH HHSUnited StatesP01HL107152PubMed and NIHNIH RePORTER
R01 HL90586NHLBI NIH HHSUnited StatesR01HL090586PubMed and NIHNIH RePORTER

Download CSV of grants

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124316004GpIbα interacts exclusively with exosite II of thrombin.J Mol Biol2014https://conductscience.org/library/papers/24316004PubMed
223809130The transition of prothrombin to thrombin.J Thromb Haemost2013https://conductscience.org/library/papers/23809130PubMed
324635452Targeting the GPIbα binding site of thrombin to simultaneously induce dual anticoagulant and antiplatelet effects.J Med Chem2014https://conductscience.org/library/papers/24635452PubMed
421555542Binding of alpha-thrombin to surface-anchored platelet glycoprotein Ib(alpha) sulfotyrosines through a two-site mechanism involving exosite I.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/21555542PubMed
523718540Designing allosteric regulators of thrombin. Exosite 2 features multiple subsites that can be targeted by sulfated small molecules for inducing inhibition.J Med Chem2013https://conductscience.org/library/papers/23718540PubMed
621893043Identification of the site of binding of sulfated, low molecular weight lignins on thrombin.Biochem Biophys Res Commun2011https://conductscience.org/library/papers/21893043PubMed
721714536Rational design of potent, small, synthetic allosteric inhibitors of thrombin.J Med Chem2011https://conductscience.org/library/papers/21714536PubMed
810708869Regulation of blood coagulation.Biochim Biophys Acta2000https://conductscience.org/library/papers/10708869PubMed
915543318Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.Thromb Haemost2004https://conductscience.org/library/papers/15543318PubMed
1021726912Allostery in trypsin-like proteases suggests new therapeutic strategies.Trends Biotechnol2011https://conductscience.org/library/papers/21726912PubMed
119184147Energetics of thrombin-thrombomodulin interaction.Biochemistry1997https://conductscience.org/library/papers/9184147PubMed
1224516370A unified view of "how allostery works".PLoS Comput Biol2014https://conductscience.org/library/papers/24516370PubMed
1310660541
The Asp(272)-Glu(282) region of platelet glycoprotein Ibalpha interacts with the heparin-binding site of alpha-thrombin and protects the enzyme from the heparin-catalyzed inhibition by antithrombin III.
J Biol Chem2000https://conductscience.org/library/papers/10660541PubMed
1417804413A novel allosteric pathway of thrombin inhibition: Exosite II mediated potent inhibition of thrombin by chemo-enzymatic, sulfated dehydropolymers of 4-hydroxycinnamic acids.J Biol Chem2007https://conductscience.org/library/papers/17804413PubMed
1521238936Thrombin as an anticoagulant.Prog Mol Biol Transl Sci2011https://conductscience.org/library/papers/21238936PubMed
1616728654Thrombin-cofactor interactions: structural insights into regulatory mechanisms.Arterioscler Thromb Vasc Biol2006https://conductscience.org/library/papers/16728654PubMed
171003464Ion effects on ligand-nucleic acid interactions.J Mol Biol1976https://conductscience.org/library/papers/1003464PubMed
189516447Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin.J Biol Chem1998https://conductscience.org/library/papers/9516447PubMed
191450405Thrombin interaction with platelet glycoprotein Ib: effect of glycocalicin on thrombin specificity.Blood1992https://conductscience.org/library/papers/1450405PubMed
2016241939Determinants of specificity in coagulation proteases.J Thromb Haemost2005https://conductscience.org/library/papers/16241939PubMed

See all 25 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
37001055Designing Smaller, Synthetic, Functional Mimetics of Sulfated Glycosaminoglycans as Allosteric Modulators of Coagulation Factors.J Med Chem2023https://conductscience.org/library/papers/37001055PubMed
30931428Allosteric inhibition of α-thrombin enzymatic activity with ultrasmall gold nanoparticles.Nanoscale Adv2019https://conductscience.org/library/papers/30931428PubMed
30457046Sulfated Non-Saccharide Glycosaminoglycan Mimetics as Novel Drug Discovery Platform for Various Pathologies.Curr Med Chem2020https://conductscience.org/library/papers/30457046PubMed
30337351A Unique Nonsaccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation.Mol Cancer Ther2019https://conductscience.org/library/papers/30337351PubMed
29573721Novel heparin mimetics reveal cooperativity between exosite 2 and sodium-binding site of thrombin.Thromb Res2018https://conductscience.org/library/papers/29573721PubMed
27053426Allosteric Partial Inhibition of Monomeric Proteases. Sulfated Coumarins Induce Regulation, not just Inhibition, of Thrombin.Sci Rep2016https://conductscience.org/library/papers/27053426PubMed
26748875Allosterism-based simultaneous, dual anticoagulant and antiplatelet action: allosteric inhibitor targeting the glycoprotein Ibα-binding and heparin-binding site of thrombin.J Thromb Haemost2016https://conductscience.org/library/papers/26748875PubMed
26083038Development of Orally Active Thrombin Inhibitors for the Treatment of Thrombotic Disorder Diseases.Molecules2015https://conductscience.org/library/papers/26083038PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
F22147PubTator's text mininghttps://conductscience.org/library/genes/2147NCBI Gene
FGB2244PubTator's text mininghttps://conductscience.org/library/genes/2244NCBI Gene
GP1BA2811PubTator's text mininghttps://conductscience.org/library/genes/2811NCBI Gene
THBD7056PubTator's text mininghttps://conductscience.org/library/genes/7056NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25201728

GET https://conductscience.org/api/papers/v1/25201728/references?page=2